EPIDEMIOLOGICAL STUDY OF HUMAN BRUCELLOSIS IN THE KINGDOM OF SAUDI ARABIA; PRE- AND DURING COVID-19 PANDEMIC

IF 0.3 4区 农林科学 Q4 VETERINARY SCIENCES Slovenian Veterinary Research Pub Date : 2023-02-26 DOI:10.26873/svr-1645-2022
A. Alsayeqh
{"title":"EPIDEMIOLOGICAL STUDY OF HUMAN BRUCELLOSIS IN THE KINGDOM OF SAUDI ARABIA; PRE- AND DURING COVID-19 PANDEMIC","authors":"A. Alsayeqh","doi":"10.26873/svr-1645-2022","DOIUrl":null,"url":null,"abstract":"Brucellosis is one of the most reported zoonotic diseases that affects human health with subsequent economic losses.  Brucellosis is an endemic disease in countries in many regions such as the Kingdom of Saudi Arabia (KSA) in the Middle East. On 30 Jan 2020, the Director-General of the World Health Organisation (WHO) declared the novel coronavirus outbreak (later named COVID-19) a public health emergency of international concern. In KSA, on 2 March 2020, the first case of COVID-19 was confirmed. To contain the disease outbreak, partial and full suspension of public activities/curfew started in March and April. In this study, characterization of brucellosis in KSA from 2013-2019 (pre-pandemic), the year 2020 (pandemic control interventions’” year), and the year 2021is presented. Incidence data were obtained from the Ministry of Health’s (MoH) records for laboratory-confirmed cases. Extracted incidence data were analysed according to the nationality of the patients (Saudi and non-Saudi), gender (male and female), age, health regions (20 throughout KSA), and months. From 2013-2019, there were 28073 (mean; 4010) cases of human brucellosis reported. In 2020 and 2021, there were 2372 and 2400 cases of brucellosis reported, respectively. The decrease in 2021, which continued after easing PCI restrictions, is worth noting. This represents a decrease of 59.15% of reported cases compared to incidence means for the period 2013-2019. Compared to other studies, misdiagnosis, delayed diagnosis, patients not seeking medical examination, and dedicating much of the health sector for COVID-19 patients are likely reasons for brucellosis reporting reduction. However, and due to lack of additional necessary data, it is not possible currently to conclude that PCI have (or have not) influenced reducing brucellosis in KSA.  Additionally, and in comparison, to reported regional and global incidence rates of the disease, reported rates from 2013-2019 in KSA are likely to be underreported.","PeriodicalId":21765,"journal":{"name":"Slovenian Veterinary Research","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Slovenian Veterinary Research","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.26873/svr-1645-2022","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Brucellosis is one of the most reported zoonotic diseases that affects human health with subsequent economic losses.  Brucellosis is an endemic disease in countries in many regions such as the Kingdom of Saudi Arabia (KSA) in the Middle East. On 30 Jan 2020, the Director-General of the World Health Organisation (WHO) declared the novel coronavirus outbreak (later named COVID-19) a public health emergency of international concern. In KSA, on 2 March 2020, the first case of COVID-19 was confirmed. To contain the disease outbreak, partial and full suspension of public activities/curfew started in March and April. In this study, characterization of brucellosis in KSA from 2013-2019 (pre-pandemic), the year 2020 (pandemic control interventions’” year), and the year 2021is presented. Incidence data were obtained from the Ministry of Health’s (MoH) records for laboratory-confirmed cases. Extracted incidence data were analysed according to the nationality of the patients (Saudi and non-Saudi), gender (male and female), age, health regions (20 throughout KSA), and months. From 2013-2019, there were 28073 (mean; 4010) cases of human brucellosis reported. In 2020 and 2021, there were 2372 and 2400 cases of brucellosis reported, respectively. The decrease in 2021, which continued after easing PCI restrictions, is worth noting. This represents a decrease of 59.15% of reported cases compared to incidence means for the period 2013-2019. Compared to other studies, misdiagnosis, delayed diagnosis, patients not seeking medical examination, and dedicating much of the health sector for COVID-19 patients are likely reasons for brucellosis reporting reduction. However, and due to lack of additional necessary data, it is not possible currently to conclude that PCI have (or have not) influenced reducing brucellosis in KSA.  Additionally, and in comparison, to reported regional and global incidence rates of the disease, reported rates from 2013-2019 in KSA are likely to be underreported.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
沙特阿拉伯王国人类布鲁氏菌病的流行病学研究;新冠肺炎大流行前和期间
布鲁氏菌病是报道最多的人畜共患疾病之一,影响人类健康并造成经济损失。布鲁氏菌病是许多地区的地方病,如中东的沙特阿拉伯王国(KSA)。2020年1月30日,世界卫生组织(世界卫生组织)总干事宣布新型冠状病毒疫情(后命名为新冠肺炎)为国际关注的突发公共卫生事件。2020年3月2日,KSA确诊了第一例新冠肺炎病例。为了控制疾病的爆发,3月和4月开始部分和全部暂停公共活动/宵禁。在本研究中,介绍了2013-2019年(疫情前)、2020年(疫情控制干预措施“年”)和2021年KSA布鲁氏菌病的特征。发病率数据来自卫生部的实验室确诊病例记录。根据患者的国籍(沙特和非沙特)、性别(男性和女性)、年龄、健康地区(整个KSA为20个)和月份对提取的发病率数据进行分析。2013-2019年,共报告28073例(平均4010例)人类布鲁氏菌病病例。2020年和2021年,分别报告了2372例和2400例布鲁氏菌病病例。值得注意的是,在放松PCI限制后,2021年的下降仍在继续。与2013-2019年期间的发病率相比,这意味着报告病例减少了59.15%。与其他研究相比,误诊、诊断延迟、患者不寻求医疗检查以及将大部分卫生部门用于新冠肺炎患者可能是布鲁氏菌病报告减少的原因。然而,由于缺乏额外的必要数据,目前还不能得出PCI是否影响了KSA中布鲁氏菌病的减少的结论。此外,与报告的该疾病的地区和全球发病率相比,2013年至2019年KSA报告的发病率可能被低估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Slovenian Veterinary Research
Slovenian Veterinary Research VETERINARY SCIENCES-
CiteScore
0.60
自引率
0.00%
发文量
12
审稿时长
>12 weeks
期刊介绍: SLOVENIAN VETERINARY RESEARCH (ISSN 1580-4003) publishes original articles, which report the results of original research in most areas of biomedicine. The journal also publishes review articles dealing with rapidly developing areas of biomedicine or which update understanding of classical fields of biomedicine, as well as case reports, shorter scientific contributions, letters to the editor, etc.; which have not been published or are under consideration for publication elsewhere. Only papers written in English can be considered.
期刊最新文献
REVIVING THE ALPINE IBEX: ADDRESSING GENETIC AND HEALTH CONCERNS OF SLOVENIAN IBEX WITH BROADER IMPLICATIONS IN BIODIVERSITY A 2023 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE: PATHWAY FOR NEXT GENERATION OF VACCINES FIRST INSIGHT INTO GENETIC DIVERSITY OF ALPINE IBEX (Capra ibex) IN SLOVENIA INFLUENCE OF FEED RESTRICTION AND ZINC OXIDE NANOPARTICLES SUPPLEMENTATION ON GROWTH PERFORMANCE, BLOOD BIOCHEMISTRY, INTESTINAL MORPHOLOGY AND CECAL FERMENTATION PARAMETERS OF GROWING RABBITS RETROSPECTIVE ANALYSIS OF EXTRA-PELVIC INJURIES VERIFIED AT THE FIRST ADMISSION OF CATS WITH PELVIC FRACTURES
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1